MUFG Americas’s GSK GSK Stock Holding History

MUFG Americas’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,443	Closed	-$396K	–	347
2022 Q3	$396K	Sell	13,443 -1,092	-8%	-$41.4K	0.01%	323
2022 Q2	$791K	Sell	14,535 -12,327	-46%	-$681K	0.02%	281
2022 Q1	$1.46M	Sell	26,862 -19	-0.1%	-$1.03K	0.03%	242
2021 Q4	$1.48M	Sell	26,881 -2,496	-8%	-$130K	0.03%	248
2021 Q3	$1.4M	Buy	29,377 +190	+0.7%	+$9.54K	0.02%	243
2021 Q2	$1.45M	Buy	29,187 +14,530	+99%	+$698K	0.02%	240
2021 Q1	$654K	Sell	14,657 -80	-0.5%	-$3.63K	0.01%	304
2020 Q4	$678K	Sell	14,737 -1,040	-7%	-$47.8K	0.01%	302
2020 Q3	$742K	Sell	15,777 -1,009	-6%	-$50.6K	0.02%	283
2020 Q2	$856K	Sell	16,786 -80	-0.5%	-$4.1K	0.02%	269
2020 Q1	$799K	Sell	16,866 -1,308	-7%	-$69.8K	0.03%	267
2019 Q4	$1.07M	Sell	18,174 -9,120	-33%	-$507K	0.03%	283
2019 Q3	$1.46M	Buy	27,294 +202	+0.7%	+$10.4K	0.04%	250
2019 Q2	$1.35M	Hold	27,092	–	–	0.04%	254
2019 Q1	$1.42M	Sell	27,092 -1,900	-7%	-$94.9K	0.04%	239
2018 Q4	$1.39M	Buy	28,992 +11,741	+68%	+$578K	0.04%	236
2018 Q3	$866K	Sell	17,251 -499	-3%	-$25.4K	0.02%	280
2018 Q2	$894K	Sell	17,750 -929	-5%	-$46.8K	0.03%	272
2018 Q1	$912K	Sell	18,679 -3,196	-15%	-$149K	0.03%	279
2017 Q4	$970K	Sell	21,875 -19,440	-47%	-$898K	0.03%	275
2017 Q3	$2.1M	Sell	41,315 -1,023	-2%	-$51.9K	0.07%	217
2017 Q2	$2.28M	Sell	42,338 -2,856	-6%	-$152K	0.07%	213
2017 Q1	$2.38M	Sell	45,194 -5,124	-10%	-$260K	0.08%	205
2016 Q4	$2.42M	Sell	50,318 -64	-0.1%	-$3.16K	0.08%	205
2016 Q3	$2.72M	Sell	50,382 -4,984	-9%	-$273K	0.09%	198
2016 Q2	$3M	Sell	55,366 -2,786	-5%	-$147K	0.1%	190
2016 Q1	$2.95M	Buy	58,152 +2,504	+4%	+$125K	0.1%	187
2015 Q4	$2.81M	Sell	55,648 -2,800	-5%	-$143K	0.1%	187
2015 Q3	$2.81M	Buy	58,448 +5,919	+11%	+$308K	0.1%	180
2015 Q2	$2.73M	Sell	52,529 -2,495	-5%	-$140K	0.09%	186
2015 Q1	$3.17M	Buy	55,024 +9,944	+22%	+$570K	0.11%	173
2014 Q4	$2.41M	Sell	45,080 -71	-0.2%	-$3.97K	0.08%	195
2014 Q3	$2.6M	Sell	45,151 -687	-1%	-$42.1K	0.09%	183
2014 Q2	$3.06M	Buy	45,838 +153	+0.3%	+$10.4K	0.1%	173
2014 Q1	$3.05M	Sell	45,685 -2,720	-6%	-$184K	0.1%	169
2013 Q4	$3.23M	Sell	48,405 -18,395	-28%	-$1.19M	0.11%	168
2013 Q3	$4.19M	Sell	66,800 -2,763	-4%	-$178K	0.14%	137
2013 Q2	$4.36M	Buy	+69,563	New	+$4.42M	0.09%	229

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MUFG Americas's GSK Position: Q4 2022 in Review

MUFG Americas sold out of GSK (GSK) in Q4 2022, closing a stake of 13,443 shares — an estimated $396K sold.

MUFG Americas first reported a position in GSK in Q2 2013 and held it in 38 quarters. The position peaked at $4.36M in Q2 2013. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

MUFG Americas reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
MUFG Americas sold 13,443 GSK shares in Q4 2022, an estimated $396K.
MUFG Americas first reported a position in GSK in Q2 2013 and held it in 38 quarters.
MUFG Americas's GSK position peaked at $4.36M in Q2 2013.
813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on MUFG Americas's 13F filing for Q4 2022.